Roginolisib, CAS 1305267-37-1

Product Description: Roginolisib (MSC2360844; IOA-244) is a potent, orally active and selective PI3Kδ inhibitor, with an IC50 of 145 nM. Roginolisib shows highly selective against a panel of 278 additional kinases[1].

Applications: COVID-19-immunoregulation

Formula: C26H27FN4O5S

References: [1]Haselmayer P, et al. Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies. Front Immunol. 2014 May 22;5:233.

CAS Number: 1305267-37-1

Molecular Weight: 526.58

Compound Purity: 99.89

Research Area: Cancer; Inflammation/Immunology

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: PI3K

• SKU: MEXHY-135827-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-135827-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK